Ireland's reputation as a global leader in the pharma and biotech industry is well-established. With the presence of the top 24 pharma and biotech companies in the world, along with the remarkable advancements made by innovative start-ups, Ireland remains at the forefront of therapeutic breakthroughs.

In 2023, Ireland continues to experience substantial investment in this sector. Eli Lilly has recently established a greenfield site in Limerick, while Pfizer has announced plans to open a new vaccine manufacturing facility in Grange Castle. These developments underscore the growing significance of Ireland as a hub for pharma and biotech companies.

The success of any organisation within this industry hinges on the strength of its workforce. As companies offer flexible working arrangements, ample opportunities for career advancement, and an environment that fosters innovation, it becomes crucial to retain and attract top talent. To achieve this, it is essential to ensure that your remuneration packages remain competitive and aligned with the current market trends.

To assist you in this endeavour, Mason Alexander proudly presents the Pharma and Biotech 2023 Salary and Benefit Guide. This comprehensive guide has been meticulously crafted using the data gathered during the first half of this year. It serves as a valuable resource for organisations seeking to stay updated on the latest salary and benefit trends, enabling them to make informed decisions about their compensation packages.

Whether you are contemplating a career move, looking to expand your team, or simply interested in staying informed about the current landscape of the pharma and biotech industry, we encourage you to reach out to our expert consultant, Ciana. She can provide you with valuable insights, assist in your talent acquisition efforts, and offer guidance tailored to your specific needs.

Don't miss out on this opportunity to gain a competitive edge in attracting and retaining top talent. Download our 2023 pharma and biotech below and stay ahead of the curve in the dynamic world of pharma and biotech with Mason Alexander.